NASDAQ: GPCR · Biotechnology
Over the past week, Structure Therapeutics (GPCR) pulled in about 21 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 39% bullish but is deeply split: X runs 67% bullish while News sits at just 11%. Wall Street is more constructive, with 15 of 16 analysts rating GPCR a buy.
There is little buzz around GPCR this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 94% buy share sits next to a crowd that ranges from News at 11% to X at 67%. No other tracker puts the two side by side.
Across 16 analysts the consensus is a Strong Buy: 15 buy calls against 0 sell, with an average 12-month price target of $105.10.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 2 sources disagree sharply, so the read is a Sell.
Analysts sit 55 points above the crowd average of 39%, the professionals are more constructive than retail. The split is inside the crowd: X reads 67% bullish while News sits at 11%, a 56-point spread that single-source trackers miss.
Over the 30-day window, Structure Therapeutics (GPCR) buzz held subdued around 31.4 while the price drifted up 3.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 529K shares. Updated Aug 12, 2026. Over the last 7 trading days, GPCR gained 7.8%. Buzz activity in the recent week averaged 31.7 and was relatively stable, swinging between 26.6 and 41.5. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 8 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for GPCR and 1160+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live GPCR sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 12, 2026.
Based on aggregated sentiment from X and News sources, Structure Therapeutics (GPCR) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 39% bullish across 2 active sources. Those sources contribute 21 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads bearish on Structure Therapeutics (GPCR), averaging 39% bullish across 2 tracked sources over the last 7 days. The two ends of the range are X at 67% bullish and News at 11%, a 56-point spread. On the professional side, 15 of 16 analysts rate GPCR a buy.
Of the 16 analysts covering Structure Therapeutics (GPCR), 15 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $105.10. That puts the street ahead of the crowd, which averages 39% bullish.
Structure Therapeutics (GPCR) sentiment is bearish across all 2 tracked sources. X reads 67% bullish and news coverage is the most negative at 11% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
Social sentiment data shows consistently bearish discussion around Structure Therapeutics (GPCR). All 2 tracked sources lean negative, with news being the most bearish at 11% bullish. 3-day activity momentum is falling on News, while x activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 12 mentions (57% of total volume). News contributes 9 mentions. Sentiment is bearish across all sources, while x is the only source with rising 3-day activity.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. GPCR's sell signal at 93/100 conviction reflects consistently bearish sentiment across 2 tracked sources. It is a research shortcut, not financial advice.
The GPCR sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Structure Therapeutics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry sell signals, pointing to broad bearish pressure rather than an GPCR-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key